Search clinical trials for: Pasireotide LAR
Total 2372 results
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
Columbia UniversityTerminatedPituitary Tumor | ACTH-producing Pituitary TumourUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Novartis PharmaceuticalsCompleted
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaboratorsCompleted
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Mayo ClinicCompletedAutosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin AnalogsUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Hospices Civils de LyonCompleted
-
Novartis PharmaceuticalsApproved for marketing
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis Pharmaceuticals; RECORDATI GROUPCompletedNeuroendocrine Tumors | Carcinoid TumorsUnited States
-
Erasmus Medical CenterNovartisUnknown
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Novartis PharmaceuticalsCompleted
-
Radboud University Medical CenterCompletedSymptomatic Dominant Liver CystNetherlands
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Prof. Dr. Berthold SchalkeCrolll GmbhCompletedPrimary Inoperable Thymoma | Local Recurrent ThymomaGermany
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
RECORDATI GROUPRecruitingPost-Bariatric HypoglycemiaUnited States, Belgium, France, Italy, Spain, United Kingdom
-
Robert R. Henry, MDVeterans Medical Research FoundationCompletedHyperglycemiaUnited States
-
Alliance Pour La Recherche en CancerologieCompleted
-
NYU Langone HealthUnited States Department of DefenseCompletedAtypical Ductal Breast Hyperplasia | Lobular Carcinoma in Situ (LCIS) | Atypical Lobular Hyperplasia (ALH) of BreastUnited States
-
NYU Langone HealthTerminatedDuctal Carcinoma in SituUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.UnknownRefractory or Relapsed Multiple MyelomaChina
-
University of PalermoCompleted
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedPancreatic CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
Nanjing Legend Biotech Co.Janssen Research & Development, LLCRecruiting
-
Beijing Boren HospitalNanjing Legend Biotech Co.TerminatedT-cell Leukemia | T Cell LymphomaChina
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotechnology Co. The First Affiliated Hospital of USTC west...TerminatedCD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)China
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
-
Zealand University HospitalUnknownHypoglycemia, ReactiveDenmark
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Montefiore Medical CenterNovartis PharmaceuticalsWithdrawnHyperinsulinism | Insulinoma | Congenital Hyperinsulinism
-
Nobel BiocareCharite University, Berlin, GermanyUnknown
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan